Sanofi beats estimates on strong Dupixent sales, new drug launches; stock up
PositiveFinancial Markets

Sanofi has exceeded market expectations with impressive sales of its drug Dupixent and successful launches of new medications, leading to a rise in its stock price. This is significant as it highlights the company's strong performance in the competitive pharmaceutical industry, showcasing its ability to innovate and meet patient needs effectively.
— Curated by the World Pulse Now AI Editorial System










